Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 1004-1013

  Evanko, Stephen P ^a   Angello, John C ^b   Wight, Thomas N ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cell adhesion; Locomotion; Mitosis

Indexed keywords

CHONDROITIN SULFATE; HYALURONIDASE; PROTEOGLYCAN; VERSICAN;

ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LOCOMOTION; MITOSIS; PRIORITY JOURNAL; SMOOTH MUSCLE; STREPTOMYCES;

EID: 0032917384     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.1004     Document Type: Article

References (61)

1. Wight TN. The vascular extracellular matrix. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven Publishers, 1996:421-440.
2. Toole BP. Developmental role of hyaluronate. Connect Tissue Res. 1982; 10:93-100.
3. Laurent TC, Fraser JRF. Hyaluronan. FASEB J. 1992;6:2397-2404.
4. Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 1993;7:1233-1241.
5. Riessen R, Wight TN, Pastore C, Henley C, Isner JM. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation. 1996;93: 1141-1147.
6. Chajara A, Levesque H, Courel M-N, Chauzy C, Maingonnat C, Bertrand P, Delpech B. Hyaluronan and hyaluronectin production in injured rat thoracic aorta. Atherosclerosis. 1996;125:193-207.
7. Brecht M, Mayer U, Schlosser E, Prehm P. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J. 1986;239:445-450.
8. Papakonstantinou E, Karakiulakis G, Roth M, Block LH. Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1995; 92:9881-9885.
9. Jain M, He Q, Lee W-S, Kashiki S, Foster LC, Tsai J-C, Lee M-E, Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 1996;97:596-603.
10. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA. Migration of bovine aortic smooth muscle cells after wounding injury: the role of hyaluronan and RHAMM. J Clin Invest. 1995;95:1158-1168.
11. Yao LY, Moody C, Schonherr E, Wight TN, Sandell LJ. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization, and immunohistochemistry. Matrix Biol. 1994;14:213-225.
12. LeBaron RG, Zimmerman DR, Rouslahti E. Hyaluronate binding properties of versican. J Biol Chem. 1992;267:10003-10010.
13. Chang Y, Yanagashita M, Hascall VC, Wight TN. Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. J Biol Chem. 1983;258:5679-5688.
14. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem. 1991;266:17640-17647.
15. Levesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B. Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis. 1994;105:51-62.
16. Wight TN, Lara S, Riessen R, LeBaron R, Isner J. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am J Pathol. 1997;151:963-973.
17. Evanko SP, Raines EW, Ross R, Gold LI, Wight TN. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics and the proximity of PDGF and TGF-β. Am J Pathol. 1998;152:533-546.
18. Gutierrez P, O'Brien KD, Ferguson M, Nikkari ST, Alpers CE, Wight TN. Differences in the distribution of versican, deocrin, and biglycan in atherosclerotic human coronary arteries. Cardiovasc Pathol. 1997;6: 271-278.
19. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990;63:515-524.
20. Knudson W, Bartnik E, Knudson CB. Assembly of pericellular matrices by COS-7 cell transfected with CD44 lymphocyte-homing receptor genes. Proc Natl Acad Sci U S A. 1993;90:4003-4007.
21. Brown AH. Determination of pentose in the presence of large quantities of glucose. Arch Biochem Biophys. 1946;11:269-278.
22. Koyama N, Seki J, Vergel S, Mattson EJR, Yednock T, Kovach NL, Harlan JM, Clowes AW. Regulation and function of an activation-dependent epitope of the β1 integrins in vascular cells after balloon injury in baboon arteries and in vitro. Am J Pathol. 1996;148:749-761.
23. Underhill CB, Nguyen H, Shizari M, Culty M. CD44 positive macrophages take up hyaluronan during lung development. Dev Biol. 1993; 155:324-336.
24. du Cros DL, LeBaron RG, Couchman JR. Association of versican with dermal matrices and is potential role in hair follicle development and cycling. J Invest Dermatol. 1995;105:426-431.
25. Wight TN, Ross R. Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima. J Cell Biol. 1975;67:660-674.
26. DeBelder AN, Wik KO. Preparation and properties of fluorescein-labelled hyaluronate. Carhohydr. Res. 1975;44:251-257.
27. Clarris BJ, Fraser JRE. On the pericellular zone of some mammalian cells in vitro. Exp Cell Res. 1968;49:181-193.
28. Eggli PS, Graber W. Association of hyaluronan with rat vascular endothelial cells and smooth muscle cells. J Histochem Cytochem. 1995;43: 689-697.
29. Yeo T-K, Yeo K-T, Wight TN. Differential transport kinetics of chondroitin sulfate and dermatan sulfate proteoglycan by monkey aorta smooth muscle cells. Arch Biochem Biophys. 1992;294:9-16.
30. Lee GM, Johnstone B, Jacobson K, Caterson B. The dynamic structure of the pericellular matrix on living cells. J Cell Biol. 1993;123:1899-1907.
31. Knudson W, Aguiar DJ, Hua Q, Knudson CB. CD44-anchored hyaluronan-rich pericellular matrices: and ultrastructural and biochemical analysis. Exp Cell Res. 1996;228:216-228.
32. Abatangelo G, Cortivo R, Martelli M, Vecchia P. Cell detachment mediated by hyaluronic acid. Exp Cell Res. 1982;137:73-78.
33. Underhill CB, Toole BP. Binding of hyaluronate to the surface of cultured cells. J Cell Biol. 1979;82:475-484.
34. West DC, Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res. 1989;183:179-196.
35. Mast BA, Diegelmann RF, Krummel TM, Cohen IK. Hyaluronic acid modulates proliferation, collagen, and protein synthesis of cultured fetal fibroblasts. Matrix. 1993;13:441-446.
36. Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J Exp Med. 1996;183:1663-1668.
37. Hall CL, Wang C, Lange LA, Turley EA. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol. 1994;126:575-588.
38. Zhang S, Chang MCY, Zylka D, Turley S, Harrison R, Turley EA. The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J Biol Chem. 1998;273:11342-11348.
39. Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC. Interaction between the adhesion receptor, CD44 and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem. 1997;272:27913-27918.
40. Ilangumaran S, Briol A, Hoessli DC. CD44 selectively associates with active src family protein tyrosine kinases lck and fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes. Blood. 1998;91:3901-3908.
41. Rao CM, Deb TB, Datta K. Hyaluronic acid induced hyaluronic acid binding protein phosphorylation and inositol triphosphate formation in lymphocytes. Biochem Mol Biol Int. 1996;40:327-337.
42. Taher TE, Smit L, Griffionen AW, Schilder-Tol EJ, Borst J, Pals ST. Signalling through CD44 is mediated by tyrosine kinases. J Biol Chem. 1996;271:2863-2867.
43. Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P, Ponta H. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol. 1996;135:1139-1150.
44. Orlidge A, D'Amore PA. Cell specific effects of glycosaminoglycans on the attachment and proliferation of vascular wall components. Microvasc Res. 1986;31:41-53.
45. Yamagata M, Kimata K. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci. 1994;107:2581-2590.
46. Ernst H, Zanin MKB, Everman D, Hoffman S. Receptor-mediated adhesive and anti-adhesive functions of chondroitin sulfate proteoglycan preparations from embryonic chicken brain. J Cell Sci. 1995;108: 3807-3816.
47. Knudson CB, Munaim SI, Toole BP. Ectodermal stimulation of the production of hyaluronan-dependent pericellular matrix by embryonic limb mesodermal cells. Dev Dyn. 1995;204:186-191.
48. Tammi R, Tammi M. Correlations between hyaluronan and epidermal proliferation as studied by [3H]glucosamine and [3H]thymidine incorporations and staining of hyaluronan on mitotic keratinocytes. Exp Cell Res. 1991;195:524-527.
49. Barnhart BJ, Cox SH, Kraemer PM. Detachment variants of Chinese hamster cells: hyaluronic acid as a modulator of cell detachment. Exp Cell Res. 1979;119:327-332.
50. Yamagata M, Saga S, Kato M, Bernfield M, Kimata K. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts: implications for their roles in cell-substratum adhesion. J Cell Sci. 1993;106:55-65.
51. Turley EA, Torrance J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res. 1984;161:17-28.
52. Scott JE, Cummings C, Brass A, Chen Y. Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation: hyaluronan is a very efficient network forming polymer. Biochem J. 1991;274:699-705.
53. Mow VC, Mak AF, Lai WM, Rosenberg LC, Tang L-H. Viscoelastic properties of proteoglycan subunits and aggregates in varying solution concentrations. J Biomech. 1984;17:325-338.
54. Soby L, Jamieson AM, Blackwell J, Choi HU, Rosenberg LC. Viscoelastic and rheological properties of concentrated solutions of proteoglycan subunit and proteoglycan aggregate. Biopolymers. 1990;29: 1587-1592.
55. Heldin P, Suzuki M, Teder P, Pertoft H. Chondroitin sulfate proteoglycan modulates the permeability of hyaluronan containing coat around normal human mesothelial cells. J Cell Physiol. 1995;165:54-61.
56. Morgelin M, Paulsson M, Heinegard D, Aebi U, Engel J. Evidence of a defined spatial arrangement of hyaluronate in the central filament of cartilage proteoglyean aggregates. Biochem J. 1995;307:595-601.
57. Ingber DE. Cellular tensegrity: defining new rules of biological design that govern the cytoskeleton. J Cell Sci. 1993;104:613-627.
58. Perris R, Perissinotto D, Pettway Z, Bronner-Fraser M. Inhibitory effects of PG H-aggrecan and PG M-versican on avian neural crest cell migration. FASEB J. 1996;10:293-301.
59. Lohmander LS. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis. J Rheumatol Suppl. 1995;43:75-77.
60. Vernon RB, Angello JC, Iruela-Arispe ML, Lane TF, Sage EH. Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro. Lab Invest. 1992;66:536-547.
61. Chicurel ME, Singer RH, Meyer CJ, Ingber DE. Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature. 1998;392:730-733.